Comparison of intravenous (IV) and intranasal (IN) desmopressin acetate (DDAVP) in patients weighing <=50 kg with mild hemophilia A (HA) or mild to moderate von Willenbrand disease (vWd, type 1)

被引：0
|
作者：
Gill, JC
Ottum, M
Bergman, GE
机构：
[1] CENTEON LLC, KING OF PRUSSIA, PA USA
[2] MED COLL WISCONSIN, BLOOD CTR SE WISCONSIN, MILWAUKEE, WI 53226 USA
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：P2840 / P2840
页数：1
相关论文
共 14 条
  • [1] Evaluation of Stimate(R) (desmopressin acetate) Nasal Spray, 1.5 mg/mL in patients weighing <=50 kg with mild hemophilia A or mild to moderate von Willebrand disease (type 1).
    Gill, JC
    Ottum, M
    Bergman, GE
    [J]. BLOOD, 1996, 88 (10) : 1754 - 1754
  • [2] Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease
    Gill, JC
    Ottum, M
    Schwartz, B
    [J]. JOURNAL OF PEDIATRICS, 2002, 140 (05): : 595 - 599
  • [3] INTRANASAL DESMOPRESSIN (DDAVP) BY SPRAY IN MILD HEMOPHILIA-A AND VONWILLEBRANDS DISEASE TYPE-I
    LETHAGEN, S
    HARRIS, AS
    NILSSON, IM
    [J]. BLUT, 1990, 60 (03): : 187 - 191
  • [4] Safety and efficacy of Stimate(R) (desmopressin acetate, 1.5 mg/ml) nasal spray in patients with mild to moderate von Willebrand disease (vWD)
    Becton, D
    Thompson, AR
    Bergman, GE
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P2842 - P2842
  • [5] Recessive von Willebrand Disease Type 2 Normandy: Variable Expression of Mild Hemophilia and VWD Type 1
    Michiels, Jan Jacques
    Gadisseur, Alain
    Vangenegten, Inge
    Schroyens, Wilfried
    Berneman, Zwi
    [J]. ACTA HAEMATOLOGICA, 2009, 121 (2-3) : 119 - 127
  • [6] SUBCUTANEOUS CONCENTRATED DESMOPRESSIN (EMOSINT) FOR THE IN-HOSPITAL AND HOME TREATMENT OF PATIENTS WITH VON-WILLEBRAND DISEASE (VWD) AND MILD OR MODERATE HEMOPHILIA-A (HA) - PRELIMINARY-RESULTS OF A MULTICENTER ITALIAN STUDY
    CASTAMAN, G
    MANNUCCI, PM
    RODEGHIERO, F
    [J]. THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1172 - 1172
  • [7] High-dose DDAVP intranasal spray (Stimate®) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A
    Leissinger, C
    Becton, D
    Cornell, C
    Gill, JC
    [J]. HAEMOPHILIA, 2001, 7 (03) : 258 - 266
  • [8] DDAVP at a maximal dose of 15 ug administered subcutaneously is a safe and effective alternative to 20 ug IV for patients &gt;50 kg with von Willebrand disease or mild Hemophilia A.
    Mangel, J
    Laudenbach, L
    Schembri, S
    Jardine, L
    Lohmann, R
    [J]. BLOOD, 2005, 106 (11) : 510A - 510A
  • [9] Desmopressin responsiveness at a capped dose of 15 μg in type 1 von Willebrand disease and mild hemophilia A
    Siew, Dou-Anne
    Mangel, Joy
    Laudenbach, Lori
    Schembri, Sheila
    Minuk, Leonard
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2014, 25 (08) : 820 - 823
  • [10] Evaluation of Global Hemostasis Assays in Von Willebrand Disease Type 3 in Comparison with Mild to Moderate Hemophilia a
    Baby, Sreya Punjadath
    Dave, Rutvi
    Geevar, Tulasi
    Samuel, Ashok
    Rani, Jansi
    Nair, Sukesh C.
    [J]. BLOOD, 2022, 140 : 11315 - 11316
12